Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P & C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Condition:   Healthy Interventions:   Drug: Apipe (Aripiprazole10 mg);   Drug: Abilify (Aripiprazole10 mg) Sponsors:   Genuine Research Center, Egypt;   P&C  Labs, Egypt Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials